Apr 9, 2020 | All Posts, Controlled Release, Drug Bioavailability, Main Blog |
Extended Release (ER) feasibility in drug delivery continues to be an important challenge for pharmaceutical and biotech drug manufacturers. There are many factors and parameters to consider including dosage form, selecting the appropriate technology process and...
Apr 8, 2020 | All Posts, Controlled Release, Drug Bioavailability, Main Blog |
Identifying and overcoming solubility challenges continues to be an important issue for pharmaceutical and biotech drug manufacturers. Estimates of 70% of new drugs still suffer from solubility issues. As a result, industry has responded with the development of...
Sep 13, 2019 | Controlled Release, Drug Bioavailability, Main Blog, Peptide |
Beyond 2020, the global Peptide Therapeutics market is expected to eclipse $42 billion. This dramatic market increase is driven by both growing incidences of cardiovascular and metabolic diseases, and technological enhancements in peptide synthesis that include...
Recent Comments